Janux Therapeutics Inc (JANX)

56.14 -0.61 (-1.07%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Janux Therapeutics Cash and Short Term Investments (Quarterly): 658.03M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for JANX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Rezolute Inc 108.27M
Vir Biotechnology Inc 914.47M
Cytokinetics Inc 1.012B
Galectin Therapeutics Inc 27.06M
Spero Therapeutics Inc 76.29M